Maternal lipid profile differs by gestational diabetes physiologic subtype.


Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
02 2019
Historique:
received: 14 09 2018
revised: 02 11 2018
accepted: 14 11 2018
pubmed: 24 11 2018
medline: 18 5 2019
entrez: 24 11 2018
Statut: ppublish

Résumé

To characterize lipid profiles in women with different gestational diabetes mellitus (GDM) physiologic subtypes. We measured seven lipid markers (total cholesterol, LDL, HDL, triglycerides, non-esterified fatty acids (NEFA), ApoA, ApoB) in fasting plasma collected in a prospective cohort of 805 pregnant women during second trimester. We estimated insulin sensitivity and secretion using oral glucose tolerance test-based validated indices. We categorized GDM physiologic subtypes by insulin sensitivity and secretion defects defined as values below the 25th percentile among women with normal glucose tolerance (NGT), as previously established. We compared lipid markers across NGT and GDM subtypes. We explored associations between lipid markers and newborn anthropometry in the overall group and stratified by glucose tolerance status. Among 805 women, 67 (8.3%) developed GDM. Women with GDM had higher body mass index (BMI; 29.3 vs. 26.6 kg/m Women with GDM have distinct lipid profiles based on their GDM physiologic subtype which may not be apparent when investigating GDM as a single group.

Identifiants

pubmed: 30468781
pii: S0026-0495(18)30247-6
doi: 10.1016/j.metabol.2018.11.008
pmc: PMC8058811
mid: NIHMS1692244
pii:
doi:

Substances chimiques

Biomarkers 0
Lipids 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-42

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK113218
Pays : United States
Organisme : CIHR
ID : MOP 115071
Pays : Canada

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Diabetes Care. 2000 Mar;23(3):295-301
pubmed: 10868854
BJOG. 2015 Apr;122(5):643-51
pubmed: 25612005
Diabetes Care. 2016 Jun;39(6):1052-5
pubmed: 27208340
Horm Mol Biol Clin Investig. 2016 May 1;26(2):109-27
pubmed: 26351960
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Diabetes Care. 2011 Oct;34(10):2198-204
pubmed: 21775754
Diabetes Care. 2008 Sep;31(9):1858-63
pubmed: 18606978
Am J Clin Nutr. 2000 May;71(5 Suppl):1256S-61S
pubmed: 10799399
J Diabetes Complications. 1998 Jan-Feb;12(1):1-9
pubmed: 9442808
Horm Res. 2006;65 Suppl 3:59-64
pubmed: 16612115
Diabetes Care. 2007 Jul;30(7):1783-8
pubmed: 17416793
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Diabetes Care. 2001 Apr;24(4):796-7
pubmed: 11315860
BMJ Open. 2016 Feb 03;6(2):e010031
pubmed: 26842272

Auteurs

Jill Layton (J)

Department of Epidemiology, Indiana University Fairbanks School of Public Health, Indianapolis, IN, USA.

Camille Powe (C)

Diabetes Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Catherine Allard (C)

Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada.

Marie-Claude Battista (MC)

Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada.

Myriam Doyon (M)

Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada.

Luigi Bouchard (L)

Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada.

Patrice Perron (P)

Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada.

Jennifer Wessel (J)

Department of Epidemiology, Indiana University Fairbanks School of Public Health, Indianapolis, IN, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Diabetes Translational Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.

Marie-France Hivert (MF)

Diabetes Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA; Centre de Recherche du Centre hospitalier universitaire de Sherbrooke (CHUS), Québec, Canada; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: mhivert@partners.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH